TABLE 4.
Spearman’s correlation coefficient was the main correlation coefficient used.
Proteins | Groups | MCP-1 (pg/mL) | MIP-1β (pg/mL) | TNF-α (pg/mL) | |||
---|---|---|---|---|---|---|---|
r | p | r | p | r | p | ||
IGF-2 (ng/mL) | All | 0.043 | 0.791 | 0.188 | 0.244 | −0.063 | 0.701 |
C | 0.176 | 0.458 | 0.402 | 0.079 | −0.298 | 0.202 | |
BD | −0.183 | 0.439 | 0.006 | 0.98 | 0.171P | 0.471 | |
BD0 | 0.224 | 0.533 | 0.262P | 0.464 | 0.240P | 0.504 | |
BD1 | −0.234P | 0.516 | −0.067 | 0.855 | 0.203P | 0.575 | |
IGFBP-1 (ng/mL) | All | 0.463** | 0.003 | 0.148 | 0.362 | 0.043 | 0.793 |
C | 0.572** | 0.008 | 0.010P | 0.965 | 0.045P | 0.850 | |
BD | 0.377 | 0.101 | 0.129 | 0.587 | −0.153P | 0.519 | |
BD0 | 0.139 | 0.701 | 0.212P | 0.556 | −0.174P | 0.631 | |
BD1 | 0.247P | 0.492 | 0.127 | 0.726 | −0.052P | 0.866 | |
IGFBP-3 (ng/mL) | All | −0.444** | 0.004 | −0.127 | 0.435 | −0.186 | 0.251 |
C | −0.310 | 0.184 | 0.267P | 0.256 | −0.221P | 0.349 | |
BD | −0.087 | 0.715 | 0.131 | 0.582 | 0.028P | 0.907 | |
BD0 | 0.176 | 0.627 | 0.209P | 0.563 | −0.176P | 0.626 | |
BD1 | −0.639* P | 0.047 | 0.273 | 0.446 | −0.121P | 0.740 | |
IGFBP-5 (ng/mL) | All | −0.314* | 0.048 | −0.272 | 0.089 | −0.290 | 0.069 |
C | −0.177 | 0.456 | −0.058P | 0.809 | −0.374P | 0.104 | |
BD | 0.275 | 0.240 | −0.023 | 0.925 | −0.169P | 0.477 | |
BD0 | 0.152 | 0.676 | 0.414P | 0.234 | −0.023P | 0.949 | |
BD1 | −0.459P | 0.182 | −0.115 | 0.751 | −0.300P | 0.400 | |
IGFBP-7 (ng/mL) | All | 0.124 | 0.447 | 0.313* | 0.049 | −0.120 | 0.462 |
C | 0.197 | 0.405 | 0.312P | 0.181 | −0.386P | 0.093 | |
BD | −0.059 | 0.806 | 0.260 | 0.268 | −0.056 | 0.816 | |
BD0 | −0.055 | 0.881 | 0.273 | 0.446 | 0.479 | 0.162 | |
BD1 | −0.310P | 0.384 | 0.018 | 0.960 | −0.074P | 0.839 |
r, coefficient values range from −1 to 1. PPearson’s correlation coefficient was used when both distributions adjust to a normal distribution (Shapiro–Wilk test; p-value ˃ 0.05). All (n = 40), C + BD groups; C (n = 20), control group; BD (n = 20), bipolar disorder; BD0 (n = 10), bipolar disorder time 0 (before treatment at hospital admission in the longitudinal subgroup); BD1 (n = 10), bipolar disorder time 1 (after treatment at hospital admission in the longitudinal subgroup); IGF, insulin-like growth factor; IGFBP, insulin-like growth factor-binding protein; MCP-1, monocyte chemoattractant protein 1; MIP-1β, macrophage inflammatory protein 1 beta; TNF-α, tumor necrosis factor alpha. * p-value <0.05 and ** p-value <0.01.